Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
12.01
-0.28 (-2.24%)
At close: Apr 1, 2025, 4:00 PM
12.48
+0.47 (3.91%)
After-hours: Apr 1, 2025, 6:54 PM EDT

Syndax Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-318.76-209.36-149.3424.93-73.16
Upgrade
Depreciation & Amortization
0.010.010.030.040.09
Upgrade
Other Amortization
0.03----
Upgrade
Loss (Gain) From Sale of Investments
-13.47-14.8-3.380.64-0.13
Upgrade
Stock-Based Compensation
43.0330.9516.0213.329.06
Upgrade
Other Operating Activities
0.990.741.34-0.20.82
Upgrade
Change in Accounts Receivable
-11.24----
Upgrade
Change in Inventory
-0.37----
Upgrade
Change in Accounts Payable
1.675.61-1.322.16-2.67
Upgrade
Change in Unearned Revenue
----13.13-1.52
Upgrade
Change in Other Net Operating Assets
23.2126.252.981.38-3.75
Upgrade
Operating Cash Flow
-274.9-160.6-133.6829.13-71.26
Upgrade
Capital Expenditures
----0.13-
Upgrade
Sale of Property, Plant & Equipment
--0.23--
Upgrade
Investment in Securities
-219.78117.61-186.41-40.74-142.53
Upgrade
Investing Cash Flow
-219.78117.61-186.19-40.87-142.53
Upgrade
Long-Term Debt Issued
----19.73
Upgrade
Long-Term Debt Repaid
---21--
Upgrade
Net Debt Issued (Repaid)
---21-19.73
Upgrade
Issuance of Common Stock
9.72264.13193.25117.89284.69
Upgrade
Other Financing Activities
343.65--0.580
Upgrade
Financing Cash Flow
353.37264.13172.25118.46304.42
Upgrade
Net Cash Flow
-141.31221.14-147.61106.7290.63
Upgrade
Free Cash Flow
-274.9-160.6-133.6829-71.26
Upgrade
Free Cash Flow Margin
-1160.91%--20.76%-4697.43%
Upgrade
Free Cash Flow Per Share
-3.21-2.28-2.200.54-1.73
Upgrade
Cash Interest Paid
--2.0621.63
Upgrade
Levered Free Cash Flow
-155.26-82.37-76.2732.03-38.44
Upgrade
Unlevered Free Cash Flow
-152.21-82.24-74.3133.22-36.97
Upgrade
Change in Net Working Capital
-17.05-30.52-4.48-3.61.48
Upgrade
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q